F1000 Announces Appointment of Rebecca Lawrence as Managing Director

London, United Kingdom, November 20, 2015 --(PR.com)-- F1000, a provider of services to biomedical researchers to support the discovery, writing and publication of new scientific findings, has announced the appointment of Rebecca Lawrence as Managing Director. Lawrence was previously Managing Director of F1000 Research Ltd, the publishing arm of F1000.

During the 6 years she has worked at F1000, Lawrence has launched and established both F1000Research (the open science publishing platform) and F1000Posters (the open access repository of posters and slides, now incorporated into F1000Research). Lawrence, who has over 15 years’ experience in the STM publishing industry, is also co-Chair of several international initiatives around peer review recognition and data sharing, working with ORCID, CASRAI, RDA, BioSharing and other major organisations.

This appointment marks an important transition for F1000 in moving towards an integrated suite of products overseen by the F1000 Faculty, a unique and prestigious group of over 11,000 experts across biology and medicine. F1000 are now working with major research funders and institutions around the world to utilise the tools and services F1000 have built over the past 13 years. The objective is to address the major challenges that researchers face in trying to write and publish their findings, and in the way they are subsequently evaluated for future careers and grants.

Vitek Tracz, Chairman & CEO, F1000, said: “Rebecca Lawrence has shown a clear grasp of the issues we address and demonstrated an outstanding ability to change these into practical and useful services. I am confident she will play a central role in creating the new environment that researchers need science publishers to develop.”

Lawrence said: “I am delighted to take on this new role at F1000 and am looking forward to the challenges ahead. F1000 is in a truly unique position to help make a sea-change in how new findings are shared, researchers are evaluated, and ultimately in how the whole scientific enterprise functions, for the good of science and ultimately for healthcare. There now seems to be a palpable desire, amongst both scientists and those involved in policy, to change the system that is getting increasingly skewed and biased by the current publishing and evaluation system. I feel incredibly privileged to be able to play an important role in this transformative journey.”

For more information:
Andrew Baud, Tala (on behalf of F1000), +44 (0) 20 3397 3383 or +44 (0) 7775 715775

Notes to editors
F1000 was founded by science publishing entrepreneur Vitek Tracz, a passionate advocate of open access publishing and open science. F1000 is a community of more than 11,000 biomedical experts who help scientists to discover, discuss and publish research. F1000 offers the following services:
F1000Research - an open science publishing platform for life scientists that offers immediate publication and transparent peer review, avoiding editorial bias and ensuring the inclusion of all source data.

F1000Prime - a service which identifies and recommends important articles in biology and medical research publications.

F1000Workspace - a new research collaboration, reference management and authoring platform for scientists.

For more information go to www.f1000.com